Stanford Health Care
About Stanford Clinical LaboratoryLicensureContact Us

Home
Test Directory

Test Requisitions Specimen Collection
Critical Values
Administrative Department
Clinical DepartmentsDepartment of PathologyEsoteric DepartmentsFeatured Services



MGMT PROMOTER METHYLATION, NON-BLOOD

Test Code: MGMT
Description: Gliomas are the most common primary brain tumors. Presence of promoter methylation, which causes epigenetic silencing of the MGMT gene, a DNA repair gene on chromosome 10q26, is a positive predictive factor for chemotherapeutic response to alkylating agents in the treatment of gliomas. The methylation status of the MGMT promoter is determined by methylation-specific PCR analysis (MSP). The DNA is amplified with primers specific for the methylated and the unmethylated product.

 
 


 
Home | About Stanford Clinical Laboratories | Careers | Contact Us | Legal Notices & Disclaimer